Quantcast
 
Learn to trade in these market conditions - Click here Just Released!


 

InvestSource, Inc.: Somatic Systems, Inc. Completes Round of Share Buybacks

Thu. September 25, 2008; Posted: 04:35 AM
Stocks RSS
Sep 25, 2008 (M2 PRESSWIRE via COMTEX) -- SMAS | Quote | Chart | News | PowerRating -- Stocks in the News: Somatic Systems, Inc. (PINKSHEETS: SMAS), Cryo-Cell International, Inc. (OTCBB: CCEL), Patient Portal Technologies, Inc. (OTCBB: PPRG), Chemed Corporation (NYSE: CHE)

Sep 23, 2008 -- Somatic Systems, Inc. (PINKSHEETS: SMAS | Quote | Chart | News | PowerRating) announced today that it has completed its fourth round of share buybacks, retiring another half billion shares of its common stock. Prior to the beginning of this aggressive buyback program, Somatic Systems had approximately 8 billion shares of common stock issued and outstanding. Cancellation of this round of shares brings the structure down to approximately five-and-a-half billion shares, eliminating over one quarter of the company's stock. The sizable elimination of shares has all been completed within the one month since Somatic Systems announced it would begin a massive share acquisition and cancellation program, to restructure the company's capital and grow share price without conducting a reverse split of the stock. Furthermore, the company has stated its intention to continue to acquire and retire additional shares.

Sep 24, 2008 -- Cryo-Cell International, Inc. (OTCBB: CCEL), one of the world's largest private cord blood banks and a developer of innovative stem cell solutions, announced today that the Company has entered into agreements to launch its proprietary new service, C'elle(TM), to seven countries in Europe, Latin America and Southeast Asia. Cryo-Cell's innovative service, introduced in November, 2007, is the first available service that enables women to collect and cryopreserve highly prolific stem cells harvested from menstrual flow. C'elle was developed by researchers at Cryo-Cell following the Company's discovery of unique and highly prolific stem cells in menstrual fluid. "We are very excited to partner with Cryo-Cell International to distribute C'elle throughout Ireland and the UK," said Michael Doherty, Managing Director, Medicare Health & Living Ltd. "Cryo-Cell International is renowned for its high standards and excellence. We believe that C'elle has the potential to revolutionize women's health globally. This is truly a great opportunity to bring an exclusive and innovative product to the women of Ireland and the UK enabling them to store their very own portfolio of stem cells." Cryo-Cell continues to explore new global commercial and scientific partnerships and recognizes that the regenerative potential of C'elle may one day help to advance women's healthcare around the world. With the international launch of C'elle, Cryo-Cell's global partners will have a unique opportunity to expand their business models with a proprietary and highly differentiated service. Distribution of the C'elle service outside the United States may potentially create new sources of revenue for Cryo-Cell generated from technology license and royalty fees, along with processing and storage revenues for the service. "We believe that the globalization of C'elle may generate significant worldwide awareness and interest in the potential of future stem cell therapeutic breakthroughs," said Mercedes Walton, Chairman and CEO of Cryo-Cell International. "We are pleased that our exclusive service, C'elle, will be introduced to women in different countries around the world. This exclusive and innovative service, based on Cryo-Cell's expansive intellectual property portfolio, provides women with the opportunity to store their own stem cells for future potential therapeutic benefit."

Sep 24, 2008 -- Patient Portal Technologies, Inc. (OTCBB: PPRG | Quote | Chart | News | PowerRating) announced today that it has signed an agreement to provide HealthCast(tm) customized patient network services to the Iroquois Nursing Home, a quality residential and short term rehabilitative care facility in Syracuse, NY. The agreement includes multiple health education channels and a customized information network to enhance communications between patients and facility. "We are excited to be working with Iroquois Nursing Home, one of Central New York's newest skilled nursing facilities,'' said Kevin Kelly, President of Patient Portal Technologies, Inc. ''This agreement, combined with our previous hospital sales, demonstrates the scalability and economic value of our HealthCast(tm) platform across a wide range of healthcare institutions. This validates the market demand for our HealthCast product and we see tremendous growth opportunity as we expand this product to other long-term care facilities. This opportunity to work closely with a known leader like the Iroquois Nursing Home is ideal for providing our unique HealthCast platform in the upstate New York region. We see a growing demand for this service in the long term healthcare market. Being selected as the provider of choice demonstrates our ability to deliver the right services at the right cost.''

Sep 24, 2008 -- VITAS Innovative Hospice Care , a member of the Chemed Corporation (NYSE: CHE), and Medical Mutual have signed a national agreement to ensure access to quality hospice services for Medical Mutual members who reside in major metro markets served by VITAS. Medical Mutual, formerly Medical Mutual of Ohio, serves 3 million members in the State of Ohio and in Western Pennsylvania, as well as another 200,000 in Georgia as a result of the recent purchases of Consumers Life Insurance Company, Northeast Georgia Partners and First Medical Network. VITAS, one of the nation's oldest and one of the nation's largest hospice providers, currently serves patients in Ohio through its hospice programs in Cincinnati, Dayton, Columbus and Cleveland. VITAS serves patients in Western Pennsylvania through its hospice program offices in Pittsburgh, Butler and Jeannette. In Georgia, VITAS serves patients throughout the Greater Atlanta metropolitan area through offices and inpatient units located in Atlanta, Stockbridge and Cartersville. "VITAS has expanded significantly in Ohio, Pennsylvania, and Georgia in recent years," noted Tim O'Toole, CEO of VITAS Innovative Hospice Care. "Partnering with Medical Mutual will enable VITAS to better meet the ever-increasing demand for quality, compassionate, responsive end-of-life care for residents of Ohio, Western Pennsylvania, and Georgia who seek to maximize quality of life when they have a limited time to live."

Market Wrap for September 24th, 2008 Wednesday's trading was generally range bound until stocks fell to a session low shortly before the closing bell. They managed to finish near the unchanged mark as the session expired. Action was underscored by light volume as traders assessed testimonies from key financial officials and continue awaiting a clear indication whether an asset funding plan will win approval. Their reservation overshadowed a symbolic vote of confidence from a renowned investor. Famed value investor Warren Buffett gave investors encouragement this morning on word his Berkshire Hathaway bought $5 billion in perpetual preferred stock from Goldman Sachs. Berkshire will also receive warrants to purchase $5 billion of GS common stock at any time within five years. Goldman also priced a $5.0 billion common stock public offering at $123 per share. Though the investment reflected Buffett's confidence in the firm and that the government will stabilize the financial markets, traders remained wary. The Treasury's proposal to buy up to $700 billion in illiquid assets from financial institutions remains in focus. Fed Chairman Bernanke stated before the Joint Economic Committee that the stabilization of the financial system is key to an economic recovery since the crisis is affecting the broader economy. Economic activity appears to be decelerating, though Bernanke expects GDP to expand in the second half. Still, he believes it will grow below its potential rate. The primary culprit undermining economic growth has been a weak housing market. August existing home sales fell 2.2% to an annual seasonally adjusted rate of 4.91 million, according to the National Association of Realtors. Sales were expected to fall 1.2%. Treasury Secretary Paulson stated before the House of Financial Services Committee that stabilizing the U.S. financial system must be done to avoid a continuing series of financial institution failures and frozen credit markets. He also stated the proposed $700 billion program is about benefiting American people since their economic well-being is at risk. Paulson stated the troubled asset purchase program is the single most effective move to help homeowners, citizens, and the economy. Government officials continue to pepper Bernanke and Paulson with questions and have yet to clearly indicate favor for the proposed plan. That has kept traders at bay. In turn, trading volume on the NYSE just passed 1 billion shares. That is only one-third of the volume seen last Friday, when the exchange posted record high volume. The S&P 500 closed the session with a 0.2% loss. It fluctuated between a gain of 0.8% and a loss of 0.7% during the session. In the end, six of the ten economic sectors finished higher, though not one provided leadership.

ABOUT INVESTSOURCE, INC.: WIN an 8 day 7 nights Caribbean Getaway, GO TO: www.investsourceinc.com.

To hear "The Fastest 60 Seconds in the Small-Cap Market," please go to www.ceo-corner.com This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation to buy or sell securities. InvestSource, Inc. has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by InvestSource, Inc. to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this release have not given an opinion or approved the statements made in this release.

InvestSource, Inc. is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. InvestSource, Inc. affiliates, officers, directors and employees may also have bought, or may buy the shares discussed in this opinion and may profit in the event of a rise in value. InvestSource, Inc. will not advise as to when it decides to sell and does not, and will not, offer any opinion as to when others should buy or sell; each investor must make that decision based on his or her judgment of the market. Please consult your broker before purchasing or selling any securities mentioned herein. To view full disclaimers, please go to http://investsourceinc.com/content/disclaimer.php (disclaimers).

CONTACT: InvestSource, Inc e-mail: info@investsourceinc.com WWW: http://www.investsourceinc.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Chemed Corp (CHE) click here. Chemed Corp (CHE) has Short Term PowerRatings of 4. Details on Chemed Corp (CHE) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [CHE]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.